Skip to content

Clinical trials

Phase 2 Kidney Calculi trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Kidney Calculi Phase: Phase 2 Country / region: United States Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20103
20121
20131
20141
20152
20172
20182
20221
20231
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Terminated2
Recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Allena Pharmaceuticals4
University of Texas Southwestern Medical Center2
Alnylam Pharmaceuticals1
Lilac Therapeutics, Inc.1
Mission Pharmacal1
Takeda1
Thomas Chi, MD1
University of Michigan1
University of North Carolina, Chapel Hill1
Watson Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Kidney Calculi16
Nephrolithiasis5
Hyperoxaluria4
Kidney Diseases4
Urolithiasis4
Urologic Diseases3
Hyperoxaluria, Primary2
Renal Colic2
Cystinuria1
Emergencies1

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.